These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31190442)

  • 1. Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.
    Nagarajan R; Gerbing R; Alonzo T; Johnston DL; Aplenc R; Kolb EA; Meshinchi S; Barakat LP; Sung L
    Cancer Med; 2019 Aug; 8(9):4454-4464. PubMed ID: 31190442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
    Johnston DL; Nagarajan R; Caparas M; Schulte F; Cullen P; Aplenc R; Sung L
    PLoS One; 2013; 8(9):e74549. PubMed ID: 24040278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Reported Outcome Coordinator Did Not Improve Quality of Life Assessment Response Rates: A Report from the Children's Oncology Group.
    Johnston D; Gerbing R; Alonzo T; Aplenc R; Nagarajan R; Schulte F; Cullen P; Sung L
    PLoS One; 2015; 10(4):e0125290. PubMed ID: 25915772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
    Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
    Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module.
    Varni JW; Burwinkle TM; Katz ER; Meeske K; Dickinson P
    Cancer; 2002 Apr; 94(7):2090-106. PubMed ID: 11932914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.
    Aplenc R; Meshinchi S; Sung L; Alonzo T; Choi J; Fisher B; Gerbing R; Hirsch B; Horton T; Kahwash S; Levine J; Loken M; Brodersen L; Pollard J; Raimondi S; Kolb EA; Gamis A
    Haematologica; 2020 Jul; 105(7):1879-1886. PubMed ID: 32029509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains.
    Varni JW; Burwinkle TM; Limbers CA; Szer IS
    Health Qual Life Outcomes; 2007 Feb; 5():9. PubMed ID: 17295915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy.
    Peipert JD; Yount SE; Efficace F; Loefgren C; Pierson R; He J; Cella D
    Cancer; 2020 Aug; 126(15):3542-3551. PubMed ID: 32463931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio
    Pollard JA; Alonzo TA; Gerbing R; Brown P; Fox E; Choi J; Fisher B; Hirsch B; Kahwash S; Getz K; Levine J; Brodersen LE; Loken MR; Raimondi S; Tarlock K; Wood A; Sung L; Kolb EA; Gamis A; Meshinchi S; Aplenc R
    J Clin Oncol; 2022 Jun; 40(18):2023-2035. PubMed ID: 35349331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group.
    Horton TM; Perentesis JP; Gamis AS; Alonzo TA; Gerbing RB; Ballard J; Adlard K; Howard DS; Smith FO; Jenkins G; Kelder A; Schuurhuis GJ; Moscow JA
    Pediatr Blood Cancer; 2014 Oct; 61(10):1754-60. PubMed ID: 24976003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
    Getz KD; Szymczak JE; Li Y; Madding R; Huang YV; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Mian A; Mody R; Morgan E; Raetz EA; Rubnitz J; Verma A; Winick N; Wilkes JJ; Yu JC; Fisher BT; Aplenc R
    JAMA Netw Open; 2021 Oct; 4(10):e2128385. PubMed ID: 34709389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.
    Schultz KA; Chen L; Kunin-Batson A; Chen Z; Woods WG; Gamis A; Kawashima T; Oeffinger KC; Nicholson HS; Neglia JP
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):20-25. PubMed ID: 27906794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.
    Sung L; Aplenc R; Alonzo TA; Gerbing RB; Wang YC; Meshinchi S; Gamis AS
    Int J Cancer; 2016 Nov; 139(9):1930-5. PubMed ID: 27312107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales.
    Varni JW; Limbers CA; Burwinkle TM
    Health Qual Life Outcomes; 2007 Jan; 5():2. PubMed ID: 17201923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do quality of life or physical function at diagnosis predict short-term outcomes during intensive chemotherapy in AML?
    Timilshina N; Breunis H; Brandwein JM; Minden MD; Gupta V; O'Neill S; Tomlinson GA; Buckstein R; Li M; Alibhai SMH
    Ann Oncol; 2014 Apr; 25(4):883-888. PubMed ID: 24667720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.
    Schultz KA; Chen L; Chen Z; Kawashima T; Oeffinger KC; Woods WG; Nicholson HS; Neglia JP
    Pediatr Blood Cancer; 2014 Apr; 61(4):729-36. PubMed ID: 24285698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy.
    Niewerth D; Kaspers GJ; Jansen G; van Meerloo J; Zweegman S; Jenkins G; Whitlock JA; Hunger SP; Lu X; Alonzo TA; van de Ven PM; Horton TM; Cloos J
    J Hematol Oncol; 2016 Sep; 9(1):82. PubMed ID: 27599459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia.
    Meeske K; Katz ER; Palmer SN; Burwinkle T; Varni JW
    Cancer; 2004 Nov; 101(9):2116-25. PubMed ID: 15389475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.